↑ トップへ ← 戻る

 Drug(薬物リスト) ALL | DrugBank 

   e.g. "Sirolimus", "アダリムマブ"    Synonyms (Drugs) were also searched for.

A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z other

40 / 12,172 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名(臨床試験情報から抽出)   DrugBank   KEGG DRUG  KEGG GENES  KEGG PATHWAY   指定難病告示番号
 1   Azathioprine   Azathioprine   D00238, D03033   -   -   18件:
11,
13,
19,
35,
42,
43,
44,
45,
46,
49,
65,
66,
85,
94,
95,
96,
97,
162 
 2   Budesonide   Budesonide   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   9件:
66,
93,
94,
95,
96,
97,
98,
228,
299 
 3   Calcium   Calcium   -   -   -   24件:
6,
13,
19,
46,
49,
51,
65,
68,
75,
79,
84,
93,
94,
95,
96,
97,
214,
215,
222,
224,
235,
265,
298,
299 
 4   Cannabidiol   Cannabidiol   D10915   2件: CNR1, CNR2   1件: Neuroactive ligand-receptor interaction   13件:
6,
13,
46,
95,
96,
97,
140,
144,
145,
157,
158,
193,
271 
 5   Chloroquine   Chloroquine   D02125, D02366, D03469   -   -   4件:
46,
49,
95,
130 
 6   Chloroquine diphosphate   Chloroquine   D02125, D02366, D03469   -   -   1件:
95 
 7   Chloroquine diphosphate 250mg   Chloroquine   D02125, D02366, D03469   -   -   1件:
95 
 8   Cyclosporine   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   33件:
11,
14,
19,
20,
28,
36,
40,
41,
42,
45,
46,
49,
50,
53,
56,
58,
60,
62,
64,
65,
90,
95,
97,
162,
164,
222,
226,
228,
234,
283,
284,
285,
302 
 9   Cyclosporine-a   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   1件:
95 
 10   Denosumab   Denosumab   D03684   1件: TNFSF11   2件: Cytokine-cytokine receptor interaction, Osteoclast differentiation   7件:
46,
50,
93,
95,
96,
274,
299 
 11   Efalizumab   Efalizumab   D03959   1件: ITGAL   2件: Cell adhesion molecules (CAMs), Natural killer cell mediated cytotoxicity   8件:
11,
13,
37,
46,
53,
61,
95,
96 
 12   Erythropoietin   Erythropoietin   D03231   1件: EPOR   3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway   8件:
2,
6,
13,
22,
47,
70,
95,
96 
 13   High protein high fiber diet   -   -   -   -   2件:
93,
95 
 14   Inflectra (infliximab)   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
95 
 15   Infliximab   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   22件:
35,
37,
38,
39,
40,
41,
43,
45,
46,
49,
50,
56,
65,
84,
95,
96,
97,
98,
162,
164,
269,
271 
 16   Interleukin 2   Human interleukin-2, interleukin 2   -   -   -   9件:
46,
49,
51,
56,
63,
95,
96,
97,
271 
 17   Jkb-122   -   -   -   -   1件:
95 
 18   Lcp-tacro (tacrolimus)   Tacrolimus   D00107, D08556   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   1件:
95 
 19   Metronidazole   Metronidazole   D00409, D05016, D05017   -   -   8件:
46,
51,
63,
94,
95,
96,
97,
291 
 20   Minodronic acid   Minodronic acid   -   -   -   4件:
6,
46,
93,
95 
 21   Mycophenolate   Mycophenolic acid   D05096   2件: IMPDH1, IMPDH2   1件: Purine metabolism   33件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
84,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300 
 22   Mycophenolate mofeti   Mycophenolic acid   D05096   2件: IMPDH1, IMPDH2   1件: Purine metabolism   1件:
95 
 23   Mycophenolate mofetil   Mycophenolic acid, Mycophenolate mofetil, mycophenolate mofetil   D00752, D05094, D05095, D05096   2件: IMPDH1, IMPDH2   1件: Purine metabolism   32件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300 
 24   Orbcel-c   -   -   -   -   2件:
94,
95 
 25   Prednisolone   Prednisolone   D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   38件:
11,
13,
25,
26,
35,
38,
39,
41,
43,
44,
45,
46,
49,
50,
51,
56,
60,
61,
63,
64,
65,
66,
75,
81,
84,
85,
95,
96,
97,
113,
145,
162,
222,
269,
271,
296,
299,
300 
 26   Prednisolone sodium succinate   Prednisolone   D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
95 
 27   Prednisone   Ethanol   D00068, D02798, D04855, D06542   -   -   43件:
2,
11,
13,
14,
26,
35,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
61,
63,
64,
65,
66,
81,
84,
85,
86,
95,
96,
97,
113,
162,
164,
222,
224,
228,
251,
283,
284,
285,
288,
299,
300,
331 
 28   Raptiva 100 mg/ml powder and solvent for solution for injection   Efalizumab   D03959   1件: ITGAL   2件: Cell adhesion molecules (CAMs), Natural killer cell mediated cytotoxicity   7件:
11,
13,
46,
53,
61,
95,
96 
 29   Regulatory t cells   -   -   -   -   1件:
95 
 30   Risedronic acid   Risedronic acid   D00942, D03234, D08484   1件: FDPS   1件: Terpenoid backbone biosynthesis   3件:
93,
95,
274 
 31   Spif   -   -   -   -   1件:
95 
 32   Synthetic preimplantation factor   -   -   -   -   1件:
95 
 33   Tacrolimus   Tacrolimus   D00107, D08556   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   29件:
2,
11,
13,
36,
46,
49,
50,
51,
53,
60,
61,
62,
65,
66,
85,
95,
96,
97,
113,
151,
158,
164,
222,
224,
226,
228,
283,
284,
299 
 34   Treatment with azathioprin   -   -   -   -   1件:
95 
 35   Treatment with mycophenolat mofetil   -   -   -   -   1件:
95 
 36   Ursodeoxycholic acid   Ursodeoxycholic acid   D00734   1件: NR1H4   1件: Bile secretion   8件:
6,
67,
84,
93,
94,
95,
96,
97 
 37   Ursodeoxycholic acid combination of immunosuppressive agents   Ursodeoxycholic acid   D00734   1件: NR1H4   1件: Bile secretion   2件:
93,
95 
 38   Vay736   -   -   -   -   7件:
13,
35,
46,
49,
53,
85,
95 
 39   Vitamin d   Vitamin D   -   -   -   18件:
13,
19,
41,
46,
49,
50,
68,
93,
95,
96,
98,
179,
222,
228,
235,
274,
298,
299 
 40   Zoledronic acid   Zoledronic acid   D01968, D06378, D06379, D08689   1件: FDPS   1件: Terpenoid backbone biosynthesis   9件:
6,
13,
46,
93,
95,
96,
274,
299,
333 

先頭へ